Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma

European Journal of Surgical Oncology

Volumn 32, Issue 7, 2006, Pages 773-779

  Sasaki, A ^a,b   Iwashita, Y ^a   Shibata, K ^a   Ohta, M ^a   Kitano, S ^a   Mori, M ^b  

^a OITA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemoembolization; Hepatic resection; Hepatocellular carcinoma; Lipiodolization; Prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; IODINATED POPPYSEED OIL; LIPIODOL ULTRAFLUIDE; MITOMYCIN; MITOMYCIN C; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PORTAL VEIN; PREOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PREOPERATIVE CARE; SURVIVAL RATE;

EID: 33747763295     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.04.002     Document Type: Article

References (30)

1. Ikai I., Arii S., Kojiro M., et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101 (2004) 796-802
2. Poon R.T.P., Fan S.T., Lo C.M., Liu C.L., and Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 2 (1999) 216-222
3. Nagasue N., Galizia G., Kohno H., et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 106 (1989) 81-86
4. Adachi E., Matsumata T., Nishizaki T., Hashimoto H., Tsuneyoshi M., and Sugimachi K. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 72 (1993) 3593-3598
5. Wu C.C., Ho Y.Z., Ho W.L., Wu T.C., Liu T.J., and Peng F.K. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82 (1995) 122-126
6. Yamasaki S., Hasegawa H., Kinoshita H., et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87 (1996) 206-211
7. Uchida M., Kohno H., Kubota H., et al. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 20 (1996) 326-331
8. Majno P.E., Adam R., Bismuth H., et al. Influence of preoperative transarterial Lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226 (1997) 688-703
9. Paye F., Jagot P., Vilgrain V., Farges O., Borie D., and Belghiti J. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. Arch Surg 133 (1998) 767-772
10. Lu C.D., Peng S.Y., Jiang X.C., Chiba Y., and Tanigawa N. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg 23 (1999) 293-300
11. Sugo H., Futagawa S., Beppu T., Fukasawa M., and Kojima K. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg 27 (2003) 1295-1299
12. Imamura H., Matsuyama Y., Miyagawa Y., et al. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 86 (1999) 1032-1038
13. Nakashima K., Kitano S., Kim Y.I., Aramaki M., and Kawano K. Postoperative adjuvant infusion chemotherapy for patients with hepatocellular carcinoma. Hepatogastroenterology 43 (1996) 1410-1414
14. Mathurin P., Raynard B., Dharancy S., et al. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther 17 (2003) 1247-1261
15. Yamada R., Sato M., Kawabata M., Nakatsuka H., Nakamura K., and Takashima S. Hepatic arterial embolization in 120 patients with unresectable hepatoma. Radiology 148 (1983) 397-401
16. Ohishi H., Uchida H., Yoshimura H., et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154 (1985) 25-29
17. The Liver Cancer Study Group of Japan. Classification of primary liver cancer, First English edition. Kanehara and Co., Ltd., Tokyo, Japan.
18. In: Wittekind Ch., and Sobin L.H. (Eds). UICC TNM Classification of malignant tumours. 5th ed. (1997), John Wiley & Sons, New York
19. Tsai T.J., Chau G.Y., Lui W.Y., et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127 (2000) 603-608
20. Sasaki A., Kai S., Iwashita Y., Hirano S., Ohta M., and Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 103 (2005) 299-306
21. Okusaka T., Okada S., Ueno H., et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 95 (2002) 1931-1937
22. Huang Y.S., Chiang J.H., Wu J.C., Chang F.Y., and Lee S.D. Risk of hepatic failure after transarterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 97 (2002) 1223-1227
23. Chan A.O., Yuen M.F., Hui C.K., Tso W.K., and Lai C.L. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 94 (2002) 1747-1752
24. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
25. Pelletier G., Ducreux M., Gay F., et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 29 (1998) 129-134
26. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
27. Madden M.V., Krige J.E., Bailey S., et al. Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34 (1993) 1598-1600
28. Kojiro M., Sugihara S., Kakizoe S., Nakashima O., and Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol 23 Suppl (1989) S4-S8
29. Sasaki A., Yokoyama S., Nakayama I., Nakashima K., Kim Y.I., and Kitano S. Sarcomatoid hepatocellular carcinoma with osteoclast-like giant cells: case report and immunohistochemical observations. Pathol Int 47 (1997) 318-324
30. Kim Y.B., Park Y.N., and Park C. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology 38 (2001) 160-166